[1]
|
Justice, R.W., Zilian, O., Woods, D.F., Noll, M. and Bryant, P.J. (1995) The Drosophila Tumor Suppressor Gene Warts Encodes a Homolog of Human Myotonic Dystrophy Kinase and Is Required for the Control of Cell Shape and Proliferation. Genes & Development, 9, 534-546. https://doi.org/10.1101/gad.9.5.534
|
[2]
|
Xu, T., Wang, W., Zhang, S., Stewart, R.A. and Yu, W. (1995) Identifying Tumor Suppressors in Genetic Mosaics: The Drosophila Lats Gene Encodes a Putative Protein Kinase. Development, 121, 1053-1063.
https://doi.org/10.1242/dev.121.4.1053
|
[3]
|
Kango-Singh, M., Nolo, R., Tao, C., Verstreken, P., Hiesinger, P.R., Bellen, H.J., et al. (2002) Shar-Pei Mediates Cell Proliferation Arrest during Imaginal Disc Growth in Drosophila. Development, 129, 5719-5730.
https://doi.org/10.1242/dev.00168
|
[4]
|
Tapon, N., Harvey, K.F., Bell, D.W., Wahrer, D.C., Schiripo, T.A., Haber, D., et al. (2002) Salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Lines. Cell, 110, 467-478.
|
[5]
|
Wu, S., Huang, J., Dong, J. and Pan, D. (2003) Hippo Encodes a Ste-20 Family Protein Kinase that Restricts Cell Proliferation and Promotes Apoptosis in Conjunction with Salvador and Warts. Cell, 114, 445-456.
|
[6]
|
Udan, R.S., Kango-Singh, M., Nolo, R., Tao, C. and Halder, G. (2003) Hippo Promotes Proliferation Arrest and Apoptosis in the Salvador/Warts Pathway. Nature Cell Biology, 5, 914-920. https://doi.org/10.1038/ncb1050
|
[7]
|
Wei, X., Shimizu, T. and Lai, Z.C. (2007) Mob as Tumor Suppressor Is Activated by Hippo Kinase for Growth Inhibition in Drosophila. The EMBO Journal, 26, 1772-1781. https://doi.org/10.1038/sj.emboj.7601630
|
[8]
|
Huang, J., Wu, S., Barrera, J., Matthews, K. and Pan, D. (2005) The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP. Cell, 122, 421-434.
|
[9]
|
Oh, H. and Irvine, K.D. (2008) In Vivo Regulation of Yorkie Phosphorylation and Localization. Development, 135, 1081-1088. https://doi.org/10.1242/dev.015255
|
[10]
|
Chan, E.H., Nousiainen, M., Chalamalasetty, R.B., Schäfer, A., Nigg, E.A. and Silljé, H.H. (2005) The Ste20-Like Kinase Mst2 Activates the Human Large Tumor Suppressor Kinase Lats1. Oncogene, 24, 2076-2086.
https://doi.org/10.1038/sj.onc.1208445
|
[11]
|
Hao, Y., Chun, A., Cheung, K., Rashidi, B. and Yang, X. (2008) Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP. Journal of Biological Chemistry, 283, 5496-5509.
|
[12]
|
Lei, Q.Y., Zhang, H., Zhao, B., Zha, Z.Y., Bai, F., Pei, X.H., et al. (2008) TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway. Molecular and Cellular Biology, 28, 2426-2436.
https://doi.org/10.1128/MCB.01874-07
|
[13]
|
Zheng, Y. and Pan, D. (2019) The Hippo Signaling Pathway in Development and Disease. Development Cell, 50, 264-282.
|
[14]
|
Dey, A. and Varelas, X. (2020) Targeting the Hippo Pathway in Cancer, Fibrosis, Wound Healing and Regenerative Medicine. Nature Reviews Drug Discovery, 19, 480-494. https://doi.org/10.1038/s41573-020-0070-z
|
[15]
|
Nehme, N.T., Schmid, J.P., Debeurme, F., André-Schmutz, I., Lim, A., Nitschke, P., et al. (2012) MST1 Mutations in Autosomal Recessive Primary Immunodeficiency Characterized by Defective Naive T-Cell Survival. Blood, 119, 3458-3468. https://doi.org/10.1182/blood-2011-09-378364
|
[16]
|
Meng, Z., Moroishi, T. and Guan, K.L. (2016) Mechanisms of Hippo Pathway Regulation. Genes & Development, 30, 1-17. https://doi.org/10.1101/gad.274027.115
|
[17]
|
Zhao, B., Wei, X., Li, W., Udan, R.S., Yang, Q., Kim, J., et al. (2007) Inactivation of YAP Oncoprotein by the Hippo Pathway Is Involved in Cell Contact Inhibition and Tissue Growth Control. Genes & Development, 21, 2747-2761.
https://doi.org/10.1101/gad.1602907
|
[18]
|
Zhao, B., Li, L., Tumaneng, K., Wang, C.Y. and Guan, K.L. (2010) A Coordinated Phosphorylation by Lats and CK1 Regulates YAP Stability through SCF(Beta-TRCP). Genes & Development, 24, 72-85.
https://doi.org/10.1101/gad.1843810
|
[19]
|
Liu, C.Y., Zha, Z.Y., Zhou, X., Zhang, H., Huang, W., Zhao, D., et al. (2010) The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCF{Beta}-TrCP E3 Ligase. Journal of Biological Chemistry, 285, 37159-37169.
|
[20]
|
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., et al. (2008) TEAD Mediates YAP-Dependent Gene Induction and Growth Control. Genes & Development, 22, 1962-1971. https://doi.org/10.1101/gad.1664408
|
[21]
|
Kanai, F., Marignani, P.A., Sarbassova, D., Yagi, R., Hall, R.A., Donowitz, M., et al. (2000) TAZ: A Novel Transcriptional Co-Activator Regulated by Interactions with 14-3-3 and PDZ Domain Proteins. The EMBO Journal, 19, 6778-6791.
https://doi.org/10.1093/emboj/19.24.6778
|
[22]
|
Mahoney Jr., W.M., Hong, J.H, Yaffe, M.B. and Farrance, I.K. (2005) The Transcriptional Co-Activator TAZ Interacts Differentially with Transcriptional Enhancer Factor-1 (TEF-1) Family Members. Biochemical Journal, 388, 217-225.
https://doi.org/10.1042/BJ20041434
|
[23]
|
Huh, H.D., Kim, D.H. and Jeong, H.S. (2019) Regulation of TEAD Transcription Factors in Cancer Biology. Cells, 8, Article No. 600. https://doi.org/10.3390/cells8060600
|
[24]
|
Meng, Z., Moroishi, T., Mottier-Pavie, V., Plouffe, S.W., Hansen, C.G., Hong, A.W., et al. (2015) MAP4K Family Kinases Act in Parallel to MST1/2 to Activate LATS1/2 in the Hippo Pathway. Nature Communication, 6, Article No. 8357. https://doi.org/10.1038/ncomms9357
|
[25]
|
Hergovich, A. (2016) The Roles of NDR Protein Kinases in Hippo Signalling. Genes, 7, Article No. 21.
https://doi.org/10.3390/genes7050021
|
[26]
|
Lallemand, D., Curto, M., Saotome, I., Giovannini, M. and McClatchey, A.I. (2003) NF2 Deficiency Promotes Tumorigenesis and Metastasis by Destabilizing Adherens Junctions. Genes & Development, 17, 1090-1100.
https://doi.org/10.1101/gad.1054603
|
[27]
|
Bitra, A., Sistla, S., Mariam, J., Malvi, H. and Anand, R. (2017) Rassf Proteins as Modulators of Mst1 Kinase Activity. Science Report, 7, Article No. 45020. https://doi.org/10.1038/srep45020
|
[28]
|
Chau, T.L., Gioia, R., Gatot, J.S., Patrascu, F., Carpentier, I., Chapelle, J.P., et al. (2008) Are the IKKs and IKK-Related Kinases TBK1 and IKK-Epsilon Similarly Activated? Trends in Biochemical Sciences, 33, 171-180.
|
[29]
|
Hiscott, J. (2007) Convergence of the NF-κB and IRF Pathways in the Regulation of the Innate Antiviral Response. Cytokine & Growth Factor Reviews, 18, 483-490. https://doi.org/10.1016/j.cytogfr.2007.06.002
|
[30]
|
Guo, X., Zhao, Y., Yan, H., Yang, Y., Shen, S., Dai, X., et al. (2017) Single Tumor-Initiating Cells Evade Immune Clearance by Recruiting Type II Macrophages. Genes & Development, 31, 247-259.
https://doi.org/10.1101/gad.294348.116
|
[31]
|
Zhang, Y.L., Li, Q., Yang, X.M., Fang, F., Li, J., Wang, Y.H., et al. (2018) SPON2 Promotes M1-Like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways. Cancer Research, 78, 2305-2317. https://doi.org/10.1158/0008-5472.CAN-17-2867
|
[32]
|
Kim, W., Khan, S.K., Liu, Y., Xu, R., Park, O., He, Y., et al. (2018) Hepatic Hippo Signaling Inhibits Protumoural Microenvironment to Suppress Hepatocellular Carcinoma. Gut, 67, 1692-1703.
https://doi.org/10.1136/gutjnl-2017-314061
|
[33]
|
Du, X., Wen, J., Wang, Y., Karmaus, P.W.F., Khatamian, A., Tan, H., et al. (2018) Hippo/Mst Signalling Couples Metabolic State and Immune Function of CD8α+ Dendritic Cells. Nature, 558, 141-145.
https://doi.org/10.1038/s41586-018-0177-0
|
[34]
|
Du, X., Shi, H., Li, J., Dong, Y., Liang, J., Ye, J., et al. (2014) Mst1/Mst2 Regulate Development and Function of Regulatory T Cells through Modulation of Foxo1/Foxo3 Stability in Autoimmune Disease. Journal of Immunology, 192, 1525-1535. https://doi.org/10.4049/jimmunol.1301060
|
[35]
|
Li, C., Bi, Y., Li, Y., Yang, H., Yu, Q., Wang, J., et al. (2017) Dendritic Cell MST1 Inhibits Th17 Differentiation. Nature Communication, 8, Article No. 14275. https://doi.org/10.1038/ncomms14275
|
[36]
|
Zhang, Q., Meng, F., Chen, S., Plouffe, S.W., Wu, S., Liu, S., et al. (2017) Hippo Signalling Governs Cytosolic Nucleic Acid Sensing through YAP/TAZ-Mediated TBK1 Blockade. Nature Cell Biology, 19, 362-374.
https://doi.org/10.1038/ncb3496
|
[37]
|
Meng, F., Zhou, R., Wu, S., Zhang, Q., Jin, Q., Zhou, Y., et al. (2016) Mst1 Shuts off Cytosolic Antiviral Defense through IRF3 Phosphorylation. Genes & Development, 30, 1086-1100. https://doi.org/10.1101/gad.277533.116
|
[38]
|
Yuan, L., Mao, Y., Luo, W., Wu, W., Xu, H., Wang, X.L., et al. (2017) Palmitic Acid Dysregulates the Hippo-YAP Pathway and Inhibits Angiogenesis by Inducing Mitochondrial Damage and Activating the Cytosolic DNA Sensor cGAS-STING-IRF3 Signaling Mechanism. Journal of Biological Chemistry, 292, 15002-150015.
|
[39]
|
Jiao, S., Guan, J., Chen, M., Wang, W., Li, C., Wang, Y., et al. (2018) Targeting IRF3 as a YAP Agonist Therapy against Gastric Cancer. Journal of Experimental Medicine, 215, 699-718. https://doi.org/10.1084/jem.20171116
|
[40]
|
Wang, S., Xie, F., Chu, F., Zhang, Z., Yang, B., Dai, T., et al. (2017) YAP Antagonizes Innate Antiviral Immunity and Is Targeted for Lysosomal Degradation through IKKɛ-Mediated Phosphorylation. Nature Immunology, 18, 733-743.
https://doi.org/10.1038/ni.3744
|
[41]
|
Fang, C., Li, J., Qi, S., Lei, Y., Zeng, Y., Yu, P., et al. (2019) An Alternatively Transcribed TAZ Variant Negatively Regulates JAK-STAT Signaling. EMBO Reports, 20, e47227. https://doi.org/10.15252/embr.201847227
|
[42]
|
Liu, Z., Wu, C., Pan, Y., Liu, H., Wang, X., Yang, Y., et al. (2019) NDR2 Promotes the Antiviral Immune Response via Facilitating TRIM25-Mediated RIG-I Activation in Macrophages. Science Advances, 5, eaav0163.
https://doi.org/10.1126/sciadv.aav0163
|
[43]
|
Moroishi, T., Hayashi, T., Pan, W.W., Fujita, Y., Holt, M.V., Qin, J., et al. (2016) The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell, 167, 1525-1539.E17.
|
[44]
|
Hagenbeek, T.J., Webster, J.D. and Kljavin, N.M. (2018) The Hippo Pathway Effector TAZ Induces TEAD-Dependent Liver Inflammation and Tumors. Science Signaling, 11, No. 547. https://doi.org/10.1126/scisignal.aaj1757
|
[45]
|
Wang, G., Lu, X., Dey, P., Deng, P., Wu, C.C., Jiang, S., et al. (2016) Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. Cancer Discovery, 6, 80-95. https://doi.org/10.1158/2159-8290.CD-15-0224
|
[46]
|
Murakami, S., Shahbazian, D., Surana, R., Zhang, W., Chen, H., Graham, G.T., et al. (2017) Yes-Associated Protein Mediates Immune Reprogramming in Pancreatic Ductal Adenocarcinoma. Oncogene, 36, 1232-1244.
https://doi.org/10.1038/onc.2016.288
|
[47]
|
Sarkar, S., Bristow, C.A., Dey, P., Rai, K., Perets, R., Ramirez-Cardenas, A., et al. (2017) PRKCI Promotes Immune Suppression in Ovarian Cancer. Genes & Development, 31, 1109-1121. https://doi.org/10.1101/gad.296640.117
|
[48]
|
Liu, B., Zheng, Y., Yin, F., Yu, J., Silverman, N. and Pan, D. (2016) Toll Receptor-Mediated Hippo Signaling Controls Innate Immunity in Drosophila. Cell, 164, 406-419.
|
[49]
|
Lee, P.C. and Machner, M.P. (2018) The Legionella Effector Kinase LegK7 Hijacks the Host Hippo Pathway to Promote Infection. Cell Host Microbe, 24, 429-438.E6.
|
[50]
|
Geng, J., Sun, X., Wang, P., Zhang, S., Wang, X., Wu, H., et al. (2015) Kinases Mst1 and Mst2 Positively Regulate Phagocytic Induction of Reactive Oxygen Species and Bactericidal Activity. Nature Immunology, 16, 1142-1152.
https://doi.org/10.1038/ni.3268
|
[51]
|
Boro, M., Singh, V. and Balaji, K.N. (2016) Mycobacterium tuberculosis-Triggered Hippo Pathway Orchestrates CXCL1/2 Expression to Modulate Host Immune Responses. Science Report, 6, Article No. 37695.
https://doi.org/10.1038/srep37695
|
[52]
|
Cao, W., Manicassamy, S., Tang, H., Kasturi, S.P., Pirani, A., Murthy, N., et al. (2008) Toll-Like Receptor-Mediated Induction of Type I Interferon in Plasmacytoid Dendritic Cells Requires the Rapamycin-Sensitive PI(3)K-mTOR-p70S6K Pathway. Nature Immunology, 9, 1157-1164. https://doi.org/10.1038/ni.1645
|
[53]
|
Tumaneng, K., Schlegelmilch, K., Russell, R.C., Yimlamai, D., Basnet, H., Mahadevan, N., et al. (2012) YAP Mediates Crosstalk between the Hippo and PI(3)K-TOR Pathways by Suppressing PTEN via miR-29. Nature Cell Biology, 14, 1322-1329. https://doi.org/10.1038/ncb2615
|
[54]
|
Gan, W., Dai, X., Dai, X. and Xie, J. (2020) LATS Suppresses mTORC1 Activity to Directly Coordinate Hippo and mTORC1 Pathways in Growth Control. Nature Cell Biology, 22, 246-256. https://doi.org/10.1038/s41556-020-0463-6
|
[55]
|
Pai, S.G., Carneiro, B.A., Mota, J.M., Costa, R., Leite, C.A., Barroso-Sousa, R., et al. (2017) Wnt/Beta-Catenin Pathway: Modulating Anticancer Immune Response. Journal of Hematology & Oncology, 10, Article No. 101.
https://doi.org/10.1186/s13045-017-0471-6
|
[56]
|
Varelas, X., Miller, B.W., Sopko, R., Song, S., Gregorieff, A., Fellouse, F.A., et al. (2010) The Hippo Pathway Regulates Wnt/Beta-Catenin Signaling. Development Cell, 18, 579-591.
|
[57]
|
Imajo, M., Miyatake, K., Iimura, A., Miyamoto, A. and Nishida, E. (2012) A Molecular Mechanism that Links Hippo Signalling to the Inhibition of Wnt/β-Catenin Signalling. The EMBO Journal, 31, 1109-1122.
https://doi.org/10.1038/emboj.2011.487
|
[58]
|
Sharma, S., Tenoever, B.R., Grandvaux, N., Zhou, G.P., Lin, R. and Hiscott, J. (2003) Triggering the Interferon Antiviral Response through an IKK-Related Pathway. Science, 300, 1148-1151. https://doi.org/10.1126/science.1081315
|
[59]
|
Zhao, T., Wang, Z., Fang, J., et al. (2022) HTLV-1 Activates YAP via NF-κB/p65 to Promote Oncogenesis. Proceedings of the National Academy of Sciences of the United States of America, 119, e2115316119.
|